Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

eIF4E – from translation to transformation

Abstract

Over the years, studies have focused on the transcriptional regulation of oncogenesis. More recently, a growing emphasis has been placed on translational control. The Ras and Akt signal transduction pathways play a critical role in regulating mRNA translation and cellular transformation. The question arises: How might the Ras and Akt signaling pathways affect translation and mediate transformation? These pathways converge on a crucial effector of translation, the initiation factor eIF4E, which binds the 5′cap of mRNAs. This review focuses on the role of eIF4E in oncogenesis. eIF4E controls the translation of various malignancy-associated mRNAs which are involved in polyamine synthesis, cell cycle progression, activation of proto-oncogenes, angiogenesis, autocrine growth stimulation, cell survival, invasion and communication with the extracellular environment. eIF4E-mediated translational modulation of these mRNAs plays a pivotal role in both tumor formation and metastasis. Interestingly, eIF4E activity is implicated in mitosis, embryogenesis and in apoptosis. Finally, the finding that eIF4E is overexpressed in several human cancers makes it a prime target for anticancer therapies.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  • Amiri A, Keiper BD, Kawasaki I, Fan Y, Kohara Y, Rhoads RE and Strome S . (2001). Development, 128, 3899–3912.

  • Anthony B, Carter P and De Benedetti A . (1996). Int. J. Cancer, 65, 858–863.

  • Auvinen M, Laine A, Paasinen-Sohns A, Kangas A, Kangas L, Saksela O, Andersson LC and Holtta E . (1997). Cancer Res., 57, 3016–3025.

  • Bauer C, Brass N, Diesinger I, Kayser K, Grasser FA and Meese E . (2002). Int. J. Cancer, 98, 181–185.

  • Bauer C, Diesinger I, Brass N, Steinhart H, Iro H and Meese E U . (2001). Cancer, 92, 822–829.

  • Bisacchi D, Benelli R, Vanzetto C, Ferrari N, Tosetti F and Albini A . (2003). Cancer Detect. Prev., 27, 229–238.

  • Boudreau N and Myers C . (2003). Breast Cancer Res., 5, 140–146.

  • Brass N, Heckel D, Sahin U, Pfreundschuh M, Sybrecht GW and Meese E . (1997). Hum. Mol. Genet., 6, 33–39.

  • Brown EJ, Albers MW, Shin TB, Ichikawa K, Keith CT, Lane WS and Schreiber SL . (1994). Nature, 369, 756–758.

  • Cafferkey R, Young PR, McLaughlin MM, Bergsma DJ, Koltin Y, Sathe GM, Faucette L, Eng WK, Johnson RK and Livi GP . (1993). Mol. Cell. Biol., 13, 6012–6023.

  • Carter PS, Jarquin-Pardo M and De Benedetti A . (1999). Oncogene, 18, 4326–4335.

  • Chiu MI, Katz H and Berlin V . (1994). Proc. Natl. Acad. Sci. USA, 91, 12574–12578.

  • Clemens MJ . (2001). J. Cell. Mol. Med., 5, 221–239.

  • Clemens MJ and Bommer UA . (1999). Int. J. Biochem. Cell. Biol., 31, 1–23.

  • Cormier P, Pyronnet S, Morales J, Mulner-Lorillon O, Sonenberg N and Belle R . (2001). Dev. Biol., 232, 275–283.

  • Cruz MC, Cavallo LM, Gorlach JM, Cox G, Perfect JR, Cardenas ME and Heitman J . (1999). Mol. Cell. Biol., 19, 4101–4112.

  • Curtis D, Lehmann R and Zamore PD . (1995). Cell, 81, 171–178.

  • Dai Y and Grant S . (2003). Curr. Opin. Pharmacol., 3, 362–370.

  • Darveau A, Pelletier J and Sonenberg N . (1985). Proc. Natl. Acad. Sci USA, 82, 2315–2319.

  • Davidson NE, Hahm HA, McCloskey DE, Woster PM and Casero RA . (1999). Endocr. Relat. Cancer., 6, 69–73.

  • De Benedetti A and Harris AL . (1999). Int. J. Biochem. Cell. Biol., 31, 59–72.

  • De Benedetti A, Joshi-Barve S, Rinker-Schaeffer C and Rhoads RE . (1991). Mol. Cell. Biol., 11, 5435–5445.

  • De Benedetti A and Rhoads RE . (1990). Proc. Natl. Acad. Sci. USA, 87, 8212–8216.

  • DeFatta RJ, Nathan CA and De Benedetti A . (2000). Laryngoscope, 110, 928–933.

  • Detillieux KA, Sheikh F, Kardami E and Cattini PA . (2003). Cardiovasc. Res., 57, 8–19.

  • Diehl JA . (2002). Cancer Biol. Ther., 1, 226–231.

  • Dobashi Y, Takehana T and Ooi A . (2003). Curr. Med. Chem., 10, 2549–2558.

  • Downward J . (2003). Nat. Rev. Cancer., 3, 11–22.

  • Dua K, Williams TM and Beretta L . (2001). Proteomics, 1, 1191–1199.

  • Duncan R, Milburn SC and Hershey JW . (1987). J. Biol. Chem., 262, 380–388.

  • Duncan RF, Peterson H, Hagedorn CH and Sevanian A . (2003). Biochem. J., 369, 213–225.

  • Eberle J, Krasagakis K and Orfanos CE . (1997). Int. J. Cancer., 71, 396–401.

  • Fahrenkrug SC, Dahlquist MO, Clark KJ and Hackett PB . (1999). Differentiation, 65, 191–201.

  • Ferrara N, Gerber HP and LeCouter J . (2003). Nat. Med., 9, 669–676.

  • Frederickson RM, Montine KS and Sonenberg N . (1991). Mol. Cell. Biol., 11, 2896–2900.

  • Fukuchi-Shimogori T, Ishii I, Kashiwagi K, Mashiba H, Ekimoto H and Igarashi K . (1997). Cancer Res., 57, 5041–5044.

  • Gallego J . (2002). Curr. Opin. Drug Discov. Dev., 5, 777–784.

  • Gartel AL and Shchors K . (2003). Exp. Cell. Res., 283, 17–21.

  • Gingras AC, Raught B and Sonenberg N . (1999). Annu. Rev. Biochem., 68, 913–963.

  • Gingras AC, Raught B and Sonenberg N . (2001). Genes Dev., 15, 807–826.

  • Graff JR, Boghaert ER, De Benedetti A, Tudor DL, Zimmer CC, Chan SK and Zimmer SG . (1995). Int. J. Cancer, 60, 255–263.

  • Graff JR, De Benedetti A, Olson JW, Tamez P, Casero Jr RA and Zimmer SG . (1997). Biochem. Biophys. Res. Commun., 240, 15–20.

  • Graff JR and Zimmer SG . (2003). Clin. Exp. Metastasis., 20, 265–273.

  • Grens A and Scheffler IE . (1990). J. Biol. Chem., 265, 11810–11816.

  • Guo SS, Wu X, Shimodie AT, Wong J, Moatamed F and Sawicki MP . (2003). J. Endocrinol., 179, 73–79.

  • Hara K, Maruki Y, Long X, Yoshino K, Oshiro N, Hidayat S, Tokunaga C, Avruch J and Yonezawa K . (2002). Cell, 110, 177–189.

  • Heitman J, Movva NR and Hall MN . (1991). Science, 253, 905–909.

  • Helliwell SB, Wagner P, Kunz J, Deuter-Reinhard M, Henriquez R and Hall MN . (1994). Mol. B. Cell, 5, 105–118.

  • Hermeking H . (2003). Curr. Cancer Drug Targets, 3, 163–175.

  • Hershey J and Merrick W . (2000). Translational Control of Gene Expression, Sonenberg N, Hershey JWB, Mathews MB Cold Spring Harbor Laboratory Press: Cold Spring Harbor, NY, pp. 33–88.

    Google Scholar 

  • Hillary RA and Pegg AE . (2003). Biochim. Biophys. Acta., 1647, 161–166.

  • Hiremath LS, Webb NR and Rhoads RE . (1985). J. Biol. Chem., 260, 7843–7849.

  • Holcik M, Sonenberg N and Korneluk RG . (2000.). Trends Genet., 16, 469–473.

  • Houghton PJ and Huang S . (2004). Curr. Top Microbiol. Immunol., 279, 339–359.

  • Hui P, Howe JG, Crouch J, Nimmakayalu M, Qumsiyeh MB, Tallini G, Flynn SD and Smith BR . (2003). Leuk. Lymphoma., 44, 1385–1394.

  • Inoki K, Li Y, Xu T and Guan KL . (2003a). Genes Dev., 17, 1829–1834.

  • Inoki K, Li Y, Zhu T, Wu J and Guan KL . (2002). Nat. Cell Biol., 4, 648–657.

  • Inoki K, Zhu T and Guan KL . (2003b). Cell, 115, 577–590.

  • Jacinto E and Hall MN . (2003). Nat. Rev. Mol. Cell Biol., 4, 117–126.

  • Jang SK, Krausslich HG, Nicklin MJ, Duke GM, Palmenberg AC and Wimmer E . (1988). J. Virol., 62, 2636–2643.

  • Jefferies HBJ and Thomas G . (1996). Translational Control, Hershey JW, Mathews MB, Sonenberg N Cold Spring Harbor Press: Cold Spring Harbor, NY, pp. 389–409.

    Google Scholar 

  • Johnson DG and Walker CL . (1999). Annu. Rev. Pharmacol. Toxicol., 39, 295–312.

  • Keiper BD, Gan W and Rhoads RE . (1999). Int. J. Biochem. Cell Biol., 31, 37–41.

  • Kerekatte V, Smiley K, Hu B, Smith A, Gelder F and De Benedetti A . (1995). Int. J. Cancer, 64, 27–31.

  • Kevil C, Carter P, Hu B and De Benedetti A . (1995). Oncogene, 11, 2339–2348.

  • Kevil CG, De Benedetti A, Payne DK, Coe LL, Laroux FS and Alexander JS . (1996). Int. J. Cancer, 65, 785–790.

  • Kim DH and Sabatini DM . (2004). Curr. Top. Microbiol. Immunol., 279, 259–270.

  • Kim DH, Sarbassov DD, Ali Sm, King JE, Latek RR, Erdjument-Bromage H, Tempst P and Sabatini DM . (2002). Cell, 110, 163–175.

  • Kim DH, Sarbassov dos D, Ali SM, Latek RR, Guntur KV, Erdjument-Bromage H, Tempst P and Sabatini DM . (2003). Mol. Cell, 11, 895–904.

  • Klein PS and Melton DA . (1994). Science, 265, 803–806.

  • Koromilas AE, Lazaris-Karatzas A and Sonenberg N . (1992). EMBO. J., 11, 4153–4158.

  • Kunz J, Henriquez R, Schneider U, Deuter-Reinhard M, Movva NR and Hall MN . (1993). Cell, 73, 585–596.

  • Kwiatkowski DJ . (2003). Ann. Hum. Genet., 67, 87–96.

  • Lachance PE, Miron M, Raught B, Sonenberg N and Lasko P . (2002). Mol. Cell Biol., 22, 1656–1663.

  • Lai HK and Borden KL . (2000). Oncogene, 19, 1623–1634.

  • Lasko P . (2003). Dev. Cell, 5, 671–672.

  • Lazaris-Karatzas A, Montine KS and Sonenberg N . (1990). Nature, 345, 544–547.

  • Lazaris-Karatzas A, Smith MR, Frederickson RM, Jaramillo ML, Liu YL, Kung HF and Sonenberg N . (1992). Genes Dev., 6, 1631–1642.

  • Lazaris-Karatzas A and Sonenberg N . (1992). Mol. Cell Biol., 12, 1234–1238.

  • Levens DL . (2003). Genes Dev., 17, 1071–1077.

  • Li BD, Gruner JS, Abreo F, Johnson LW, Yu H, Nawas S, McDonald JC and DeBenedetti A . (2002a). Ann. Surg., 235, 732–738; discussion 738-9.

  • Li S, Sonenberg N, Gingras AC, Peterson M, Avdulov S, Polunovsky VA and Bitterman PB . (2002b). Mol. Cell Biol., 22, 2853–2861.

  • Li S, Takasu T, Perlman DM, Peterson MS, Burrichter D, Avdulov S, Bitterman PB and Polunovsky VA . (2003). J. Biol. Chem., 278, 3015–3022.

  • Lodish HF . (1974). Nature, 251, 385–388.

  • Loewith R, Jacinto E, Wullschleger S, Lorberg A, Crespo JL, Bonenfant D, Oppliger W, Jenoe P and Hall MN . (2002). Mol. Cell, 10, 457–468.

  • Long X, Spycher C, Han ZS, Rose AM, Muller F and Avruch J . (2002). Curr. Biol., 12, 1448–1461.

  • Lorenz MC and Heitman J . (1995). J. Biol. Chem., 270, 27531–27537.

  • Lynch M, Fitzgerald C, Johnston KA, Wang S and Schmidt EV . (2004). J. Biol. Chem., 279, 3327–3339.

  • Maeshima Y, Sudhakar A, Lively JC, Ueki K, Kharbanda S, Kahn CR, Sonennerg N, Hynes RO and Kalluri R . (2002). Science, 295, 140–143.

  • Malumbres M and Barbacid M . (2003). Nat. Rev. Cancer, 3, 459–465.

  • Manni A . (2002). In Vivo, 16, 493–500.

  • Manning BD and Cantley LC . (2003). Trends Biochem. Sci., 28, 573–576.

  • Manzella JM and Blackshear PJ . (1990). J. Biol. Chem., 265, 11817–11822.

  • Marygold SJ and Leevers SJ . (2002). Curr. Biol., 12, R785–R787.

  • Matsumura I, Kitamura T, Wakao H, Tanaka H, Hashimoto K, Albanese C, Downward J, Pestell RG and Kanakura Y . (1999). EMBO. J., 18, 1367–1377.

  • Menand B, Desnos T, Nussaume L, Berger F, Bouchez D, Meyer C and Robaglia C . (2002). Proc. Natl. Acad. Sci. USA, 99, 6422–6427.

  • Meyuhas O . (2000). Eur. J. Biochem., 267, 6321–6330.

  • Meyuhas O, Avni D and Shama S . (1996). Translational Control, Hershey JW, Mathews MB and Sonenberg N. Cold Spring Harbor Press: Cold Spring Harbor, NY, pp. 363–388.

    Google Scholar 

  • Mita MM, Mita A and Rowinsky EK . (2003). Clin Breast Cancer, 4, 126–137.

  • Miyamoto R, Uzawa N, Nagaoka S, Hirata Y and Amagasa T . (2003). Oral Oncol., 39, 610–618.

  • Morrish F, Giedt C and Hockenbery D . (2003). Genes Dev., 17, 240–255.

  • Morrish F and Hockenbery D . (2003). Cell Cycle, 2, 11–13.

  • Moshier JA, Dosescu J, Skunca M and Luk GD . (1993). Cancer Res., 53, 2618–2622.

  • Nathan CA, Franklin S, Abreo FW, Nassar R, de Benedetti A, Williams J and Stucker FJ . (1999). Laryngoscope, 109, 1253–1258.

  • Oldham S, Montagne J, Radimerski T, Thomas G and Hafen E . (2000). Genes Dev., 14, 2689–2694.

  • Park MT and Lee SJ . (2003). J. Biochem. Mol. Biol., 36, 60–65.

  • Parkin N, Darveau A, Nicholson R and Sonenberg N . (1988). Mol. Cell Biol., 8, 2875–2883.

  • Pause A, Belsham GJ, Gingras AC, Donze O, Lin TA, Lawrence Jr JC and Sonenberg N . (1994). Nature, 371, 762–767.

  • Pegg AE, Feith DJ, Fong LY, Coleman CS, O'Brien TG and Shantz LM . (2003). Biochem. Soc. Trans., 31, 356–360.

  • Pelengaris S and Khan M . (2003). Arch. Biochem. Biophys., 416, 129–136.

  • Pelletier J and Sonenberg N . (1988). Nature, 334, 320–325.

  • Polsky D and Cordon-Cardo C . (2003). Oncogene, 22, 3087–3091.

  • Polunovsky VA, Gingras AC, Sonenberg N, Peterson M, Tan A, Rubins JB, Manivel JC and Bitterman PB . (2000). J. Biol. Chem., 275, 24776–24780.

  • Polunovsky VA, Rosenwald IB, Tan AT, White J, Chiang L, Sonenberg N and Betterman PB . (1996). Mol. Cell Biol., 16, 6573–6581.

  • Potter CJ, Pedraza LG and Xu T . (2002). Nat. Cell Biol., 4, 658–665.

  • Poulin F, Gingras AC, Olsen H, Chevalier S and Sonenberg N . (1998). J. Biol. Chem., 273, 14002–14007.

  • Prendergast GC . (2003). Cancer Cell, 4, 244–245.

  • Prevot D, Darlix JL and Ohlmann T . (2003). Biol. Cell, 95, 141–156.

  • Proud CG . (2002). Eur. J. Biochem., 269, 5337.

  • Proud CG . (2004). Curr. Top Microbiol. Immunol., 279, 215–244.

  • Pyronnet S . (2000). Biochem. Pharmacol., 60, 1237–1243.

  • Pyronnet S, Imataka H, Gingras AC, Fukunaga R, Hunter T and Sonenberg N . (1999). EMBO. J., 18, 270–279.

  • Pyronnet S and Sonenberg N . (2001). Curr. Opin. Genet. Dev., 11, 13–18.

  • Rajasekhar VK, Viale A, Socci ND, Widemann M, Hu X and Holland EC . (2003). Mol. Cell, 12, 889–901.

  • Raught B, Gingras AC and Sonenberg N . (2001). Proc. Natl. Acad. Sci. USA, 98, 7037–7044.

  • Rhoads R.E., Joshi-Barve S and Rinker-Schaeffer C . (1993). Prog. Nucleic. Acid. Res. Mol. Biol., 46, 183–219.

  • Ribatti D, Vacca A, Dammacco F and English D . (2003). J. Hematother. Stem. Cell Res., 12, 11–22.

  • Ribatti D, Vacca A, Nico B, De Falco G, Giuseppe Montaldo P and Ponzoni M . (2002). Eur. J. Cancer, 38, 750–757.

  • Rinker-Schaeffer CW, Austin V, Zimmer S and Rhoads RE . (1992). J. Biol. Chem., 267, 10659–10664.

  • Rinker-Schaeffer CW, Graff JR, De Benedetti A, Zimmer SG and Rhoads RE . (1993). Int. J. Cancer, 55, 841–847.

  • Rosenwald IB, Chen JJ, Wang S, Savas L, London IM and Pullman J . (1999). Oncogene, 18, 2507–2517.

  • Rosenwald IB, Hutzler MJ, Wang S, Savas L and Fraire AE . (2001). Cancer, 92, 2164–2171.

  • Rosenwald IB, Kaspar R, Rousseau D, Gehrke L, Leboulch P, Chen JJ, Schnidt EV, Sonenberg N and London IM . (1995). J. Biol. Chem., 270, 21176–21180.

  • Rosenwald IB, Lazaris-Karatzas A, Sonenberg N and Schmidt EV . (1993a). Mol. Cell. Biol., 13, 7358–7363.

  • Rosenwald IB, Rhoads DB, Callanan LD, Isselbacher KJ and Schmidt EV . (1993b). Proc. Nat. Acad. Sci., USA, 90, 6175–6178.

  • Rousseau D, Gingras AC, Pause A and Sonenberg N . (1996a). Oncogene, 13, 2415–2420.

  • Rousseau D, Kaspar R, Rosenwald I, Gehrke L and Sonenberg N . (1996b). Proc. Natl. Acad. Sci., USA, 93, 1065–1070.

  • Ruegg C and Mariotti A . (2003). Cell. Mol. Life Sci., 60, 1135–1157.

  • Ruggero D and Pandolfi PP . (2003). Nat. Rev. Cancer, 3, 179–192.

  • Sabatini DM, Erdjument-Bromage H, Lui M, Tempst P and Snyder SH . (1994). Cell, 78, 35–43.

  • Saito H, Hayday AC, Wiman K, Hayward WS and Tonegawa S . (1983). Proc. Natl. Acad. Sci. USA, 80, 7476–7480.

  • Salaun P, Pyronnet S, Morales K, Mulner-Lorillon O, Belle R, Sonenberg N and Cormier P . (2003). Dev. Biol., 255, 428–439.

  • Schipper RG and Verhofstad AA . (2002). J. Histochem. Cytochem., 50, 1143–1160.

  • Schmelzle T and Hall M N . (2000). Cell, 103, 253–262.

  • Seiler N . (2003). Curr. Drug. Targets, 4, 565–585.

  • Shantz LM . (2004). Biochem. J., 377, 257–264.

  • Shantz LM and Pegg AE . (1994). Cancer Res., 54, 2313–2316.

  • Shantz LM and Pegg AE . (1999). Int. J. Biochem. Cell Biol., 31, 107–122.

  • Shepherd FA . (2001). Lung Cancer, 34 (Suppl 3), S81–9S.

  • Shinkaruk S, Bayle M, Lain G and Deleris G . (2003). Curr. Med. Chem. Anti-Cancer Agents, 3, 95–117.

  • Shuda M, Kondoh N, Tanaka K, Ryo A, Wakatsuki T, Hada A, Goseki N, Igaari T, Hatsuse K, Aihara T, Horiuchi S, Shichita M, Yamamoto N and Yamamoto M . (2000). Anticancer Res., 20, 2489–2494.

  • Smith MR, Jaramillo M, Tuazon PT, Traugh JA, Liu YL, Sonenberg N and Kung HF . (1991). New Biol., 3, 601–607.

  • Stacey DW . (2003). Curr. Opin. Cell Biol., 15, 158–163.

  • Streit M and Detmar M . (2003). Oncogene, 22, 3172–3179.

  • Tan A, Bitterman P, Sonenberg N, Peterson M and Polunovsky V . (2000). Oncogene, 19, 1437–1447.

  • Tee AR, Manning BD, Roux PP, Cantley LC and Blenis J . (2003). Curr. Biol., 13, 1259–1268.

  • Thomas T, Balabhadrapathruni S, Gallo MA and Thomas TJ . (2002). Oncol. Res., 13, 123–135.

  • Thomas T and Thomas TJ . (2003). J. Cell. Mol. Med., 7, 113–126.

  • Thornton S, Anand N, Purcell D and Lee J . (2003). J. Mol. Med., 81, 536–548.

  • Tonini T, Rossi F and Caludia PP . (2003). Oncogene, 22, 6549–6556.

  • Topisirovic I, Guzman ML, McConnell MJ, Licht JD, Culjkovic B, Neering Sj, Jordan CT and Borden KL . (2003). Mol. Cell Biol., 23, 8992–9002.

  • Vagner S, Galy B and Pyronnet S . (2001). EMBO. Rep., 2, 893–898.

  • Vermeulen K, Van Bockstaele DR and Berneman ZN . (2003). Cell Prolif., 36, 131–149.

  • Wallace HM and Caslake R . (2001). Eur. J. Gastroenterol Hepatol, 13, 1033–1039.

  • Wang S, Lloyd RV, Hutzler MJ, Rosenwald IB, Safarn MS, Patwardhan NA and Khan A . (2001). Thyroid, 11, 1101–1107.

  • Wang S, Rosenwald IB, Hutzler MJ, Pihan GA, Savas L, Chen JJ and Woda BA . (1999). Am. J. Pathol., 155, 247–255.

  • Wang TC, Cardiff RD, Zukerberg L, Lees E, Arnold A and Schmidt EV . (1994). Nature, 369, 669–671.

  • Watkins SJ and Norbury CJ . (2002). Br. J. Cancer, 86, 1023–1027.

  • Willis AE . (1999). Int. J. Biochem. Cell Biol., 31, 73–86.

  • Yang HS, Jansen AP, Komar AA, Zheng X, Merrick WC, Costes S, Lockett SJ, Sonenberg N and Colburn NH . (2003). Mol. Cell Biol., 23, 26–37.

  • Zhang H, Stallock JP, Ng JC, Reinhaard C and Neufeld TP . (2000). Genes Dev., 14, 2712–2724.

  • Zimmer SG, DeBenedetti A and Graff JR . (2000). Anticancer Res., 20, 1343–1351.

  • Zogakis TG and Libutti SK . (2001). Expert. Opin. Biol. Ther., 1, 253–275.

Download references

Acknowledgements

We thank Colin Lister, Meena Viparti and Pamela Kirk for their help. This research was supported by grants from the National Cancer Institute and Canadian Institutes of Health Research of Canada. YM is a recipient of a NCIC fellowship. EP is supported by an award to NS from CaP Cure. LR is a recipient of a CIHR fellowship. KY is supported by a NCIC operating grant to NS. LWL is supported by a CIHR operating grant to NS. NS is a James McGill Professor and Howard Hughes International Scholar.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Nahum Sonenberg.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mamane, Y., Petroulakis, E., Rong, L. et al. eIF4E – from translation to transformation. Oncogene 23, 3172–3179 (2004). https://doi.org/10.1038/sj.onc.1207549

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1207549

Keywords

This article is cited by

Search

Quick links